Nanobiotix SA - ADR NBTX shares are trading lower by 16.4% to $5.14 Thursday morning after the company priced its global follow-on offering. The offering includes 3,106,907 ADSs in the U.S. at $5.36 per ADS and 2,492,223 Ordinary Shares in Europe at €5.07 per share.
The pricing is based on the recent trading session average minus a 15% discount, in line with company resolutions.
What Else?
Johnson & Johnson Innovation's JJDC is obligated to subscribe for $25.0 million in Ordinary Shares through a Concurrent Private Placement, with an initial subscription of 3,670,294 restricted ADSs.
The total expected proceeds are approximately $55 million (€51.5 million), before deductions.
The offering is managed by global coordinators Jefferies LLC, Leerink Partners and Guggenheim.
According to data from Benzinga Pro, Nanobiotix has a 52-week high of $11.00 and a 52-week low of $1.75.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
